Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

• Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance

  “We remain confident in our ability to return to pre-pandemic operating margins in the coming years,” said Pfizer CFO David Denton.
  
  MarketWatch - 1h

• PepsiCo earnings beat estimates, but demand for drinks and snacks drops in North America

  PepsiCo's earnings topped Wall Street's estimates, but the company's revenue missed expectations, as drink and snack demand fell in North America.
  
  CNBC - 1h
• 

  Apple profits top estimates even as competition dents China iPhone sales

  Silicon Valley group says there are signs rollout of AI features will boost handset demand
  
  Financial Times - 4d
• 

  Apple reports sagging iPhone sales in China as first-quarter earnings barely beat Wall Street’s expectations

  Investors pay close attention to tech company’s foray into AI after Apple Intelligence’s glitches and inaccuracies. Apple slightly beat analysts’ expectations in its first-quarter earnings for ...
  
  The Guardian - 4d

• Levi beats earnings estimates but expects pressure this year from strong U.S. dollar

  Levi expects its sales to slow in the current fiscal year because of the strong U.S. dollar and one fewer selling week.
  
  CNBC - 5d

• Starbucks earnings top estimates, but same-store sales decline for fourth straight quarter

  Starbucks said its same-store sales fell 4%, fueled by a 6% decline in visits to its stores.
  
  CNBC - 6d

• Procter & Gamble earnings beat estimates as shoppers buy more household staples

  Procter & Gamble beat quarterly earnings and revenue estimates and also reiterated its fiscal 2025 forecast.
  
  CNBC - Jan. 22
• 

  Saab Expects Sales Growth to Top Guidance

  The company said it experienced a stronger-than-expected final quarter of the year, with global defence spending surging as nations support Ukraine while restocking their own arsenals.
  
  The Wall Street Journal - Jan. 17

• Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs

  Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.
  
  CNBC - Jan. 10

More from CNBC

• Fox reveals plans to launch subscription streaming service this year

  Fox has so far been on the sidelines of streaming, with the exception of its free, ad-supported service Tubi.
  
  CNBC - 30m

• Palantir soars more than 23% as AI powers strong earnings and guidance

  Palantir surged more than 23% in premarket trading on robust fourth-quarter results and guidance.
  
  CNBC - 10m

• PayPal shares slip as growth slows in card processing

  PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.
  
  CNBC - 17m

• Warren Buffett's Berkshire Hathaway scoops up more Sirius XM, boosting stake to 35%

  The Omaha, Nebraska-based conglomerate purchased roughly 2.3 million shares for about $54 million in separate transactions Thursday through Monday.
  
  CNBC - 1h

• Jim Cramer's top 10 things to watch in the stock market Tuesday

  China announcing retaliatory trade tariffs against the U.S. pressured Wall Street ahead of Tuesday's open.
  
  CNBC - 16m

More in Business

• Palantir soars more than 23% as AI powers strong earnings and guidance

  Palantir surged more than 23% in premarket trading on robust fourth-quarter results and guidance.
  
  CNBC - 10m

• McDonald's Shamrock Shake returns — and so does Grimace's uncle

  McDonald's is bringing back the mascot Uncle O'Grimacey, Grimace's uncle, to promote the seasonal milkshake.
  
  CNBC - 14m

• Jim Cramer's top 10 things to watch in the stock market Tuesday

  China announcing retaliatory trade tariffs against the U.S. pressured Wall Street ahead of Tuesday's open.
  
  CNBC - 16m

• PayPal shares slip as growth slows in card processing

  PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.
  
  CNBC - 17m

• One Palantir bear waves a white flag after earnings beat. Many remain.

  Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren’t quite ready to call it a buy either.
  
  MarketWatch - 18m